Clinical characteristics of COVID-19 with cardiac injury: a systematic review and meta-analysis

Linwen Zeng1, Shihui Wang1, Jianing Cai1

  • 1Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.

Insights

Older age, male gender, and comorbidities increase the risk of cardiac injury in COVID-19 patients. These patients face higher complication rates and mortality, highlighting the need for early cardiac injury prevention in COVID-19 care.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Cardiac injury is a significant predictor of poor prognosis in patients with 2019 novel coronavirus disease (COVID-19).
  • Limited research has comprehensively investigated the specific risk factors contributing to cardiac injury in COVID-19 patients.

Purpose of the Study:

  • To systematically analyze the clinical characteristics of COVID-19 patients.
  • To identify potential risk factors associated with cardiac injury in COVID-19 virus infection.

Main Methods:

  • A systematic literature search was conducted across major databases including Pubmed, Embase, Europe PMC, and CNKI.
  • Statistical analyses were performed using STATA 16.0 on data from 5726 confirmed cases across 17 studies.

Main Results:

  • Patients with cardiac injury were older, predominantly male, and had higher rates of comorbidities, clinical complications, mechanical ventilation, ICU transfer, and mortality compared to those without.
  • Elevated levels of C-reactive protein, procalcitonin, D-dimer, NT-proBNP, and creatinine were observed in patients with cardiac injury, alongside decreased lymphocyte and platelet counts.
  • Notably, cardiac injury in COVID-19 did not correlate with increased chest distress, chest pain, palpitations, smoking, or arrhythmias.

Conclusions:

  • Age, male gender, and comorbidities are identified as key risk factors for cardiac injury in COVID-19.
  • Cardiac injury in COVID-19 patients is linked to severe complications, abnormal laboratory findings, and adverse outcomes.
  • Unlike typical cardiac conditions, COVID-19-related cardiac injury does not significantly manifest with symptoms like chest pain or arrhythmias, underscoring the need for proactive prevention strategies.
Abstract

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
235
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
135
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
116
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
442
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
283
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
341